RESPONSES TO ENDOTHELIN-1, HUMAN PROENDOTHELIN (1-38) AND PORCINE PROENDOTHELIN (1-39) IN THE RAT ON INTRAVENOUS ADMINISTRATION AND IN THE BLOOD PERFUSED MESENTERY

被引:17
作者
DOUGLAS, SA [1 ]
HILEY, CR [1 ]
机构
[1] UNIV CAMBRIDGE, DEPT PHARMACOL, TENNIS COURT RD, CAMBRIDGE CB2 1QJ, ENGLAND
关键词
D O I
10.1016/0197-0186(91)90137-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human proendothelin (1-38) and porcine proendothelin (1-39) were respectively 4.3 and 19.2 times less potent than endothelin-1 as systemic pressor agents on i.v. administration but the maximum response to the porcine precursor was significantly greater than that to endothelin-1. The time courses of response were very similar for the 3 peptides. All 3 peptides caused dose-dependent depressor responses which preceded the pressor response and the rank order of potency was similar for both these systemic responses. High doses of endothelin-1 and human proendothelin (1-38) were toxic and death was preceded by disturbance of the ECG and, often, by bradycardia. Mesenteric perfusion pressure in situ was increased dose-dependently by all 3 peptides on close arterial administration without being accompanied by systemic pressor responses. The time courses of the responses were again similar. The human and porcine precursors appeared to be equipotent and approx. 10 times less potent than endothelin-1 itself. The highest doses given by this route commonly caused death which was accompained only by falls in systemic blood pressure even though changes in ECG occurred which were similar to those seen after i.v. administration. Discolouration of the gut occurred which suggested extravasation of erythrocytes had occurred. The results lend some support to the hypothesis that there is more than one type of receptor for the endothelin family of peptides and suggest that both human and porcine proendothelin have a direct action at these receptors. However, it is possible that some of their actions in vivo are mediated by rapid conversion to endothelin-1.
引用
收藏
页码:445 / 454
页数:10
相关论文
共 37 条
  • [1] ANGGARD E, 1989, J CARDIOVASC PHARM, V13, pS46
  • [2] DISTURBANCES IN THE CARDIOVASCULAR-SYSTEM CAUSED BY ENDOTHELIN AND SARAFOTOXIN
    BDOLAH, A
    WOLLBERG, Z
    AMBAR, I
    KLOOG, Y
    SOKOLOVSKY, M
    KOCHVA, E
    [J]. BIOCHEMICAL PHARMACOLOGY, 1989, 38 (19) : 3145 - 3146
  • [3] BLOCH KD, 1989, J BIOL CHEM, V264, P10851
  • [4] EFFECTS OF ENDOTHELIN ON THE CORONARY VASCULAR BED IN OPEN-CHEST DOGS
    CLOZEL, JP
    CLOZEL, M
    [J]. CIRCULATION RESEARCH, 1989, 65 (05) : 1193 - 1200
  • [5] CLOZEL M, 1989, J PHARMACOL EXP THER, V250, P1125
  • [6] REACTIVITY OF ENDOTHELIN-1 ON HUMAN AND CANINE LARGE VEINS COMPARED WITH LARGE ARTERIES INVITRO
    COCKS, TM
    FAULKNER, NL
    SUDHIR, K
    ANGUS, J
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 171 (01) : 17 - 24
  • [7] DENUCCI G, 1988, P NATL ACAD SCI USA, V85, P9797
  • [8] DORLEANSJUSTE P, 1908, BR J PHARM, V95
  • [9] ENDOTHELIUM-DEPENDENT VASCULAR ACTIVITIES OF ENDOTHELIN-LIKE PEPTIDES IN THE ISOLATED SUPERIOR MESENTERIC ARTERIAL BED OF THE RAT
    DOUGLAS, SA
    HILEY, CR
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1990, 101 (01) : 81 - 88
  • [10] NG-MONOMETHYL-L-ARGININE DOES NOT INHIBIT THE HINDQUARTERS VASODILATOR ACTION OF ENDOTHELIN-1 IN CONSCIOUS RATS
    GARDINER, SM
    COMPTON, AM
    BENNETT, T
    PALMER, RMJ
    MONCADA, S
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 171 (2-3) : 237 - 240